Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab

Aaron Lee, A K Raya, Steven Kymes, Alan Shiels, Milam A. Brantley

British Journal of Ophthalmology · 2008 · 134 citations · 14 references

Abstract

In this study cohort, the response to treatment of AMD with ranibizumab differed according to CFH genotype, suggesting that determining patients' CFH genotype may be helpful in the future in tailoring treatment for exudative AMD with intravitreal ranibizumab.

References

14